DOI: 10.12890/2019_001236

Massive Spontaneous Haemothorax after Rivaroxaban Therapy for Acute Pulmonary Embolism

Authors

  • Yan Denise Tan Department of Medicine, Sengkang General Hospital, Singhealth, Singapore
  • Kai Heng Raymond Goh Department of Medicine, Sengkang General Hospital, Singhealth, Singapore
  • Heng Joo Ng Department of Haematology, Singapore General Hospital, Singhealth, Singapore

denise.tan.yan@singhealth.com.sg

Keywords

Spontaneous haemothorax, pulmonary embolism, pulmonary infarction, rivaroxaban, anticoagulation

Abstract

Spontaneous haemothorax complicating the treatment of pulmonary embolism is rare and potentially fatal. We describe a patient with pulmonary embolism and severe pleuritic pain who developed a life-threatening haemothorax 10 days later while on rivaroxaban therapy. This case highlights the fact that severe pleuritic pain associated with pulmonary embolism may indicate subclinical infarction of tissue near the visceral pleura with an increased risk of pleural effusion and the subsequent development of a haemothorax. It is important to recognise such danger signs warranting closer attention, especially since the increased use of direct oral anticoagulants has facilitated ambulatory care and this complication may manifest in the outpatient setting.

View the entire article

Downloads

Published

2019-09-27

How to Cite

1.
Tan YD, Goh KHR, Ng HJ. Massive Spontaneous Haemothorax after Rivaroxaban Therapy for Acute Pulmonary Embolism. EJCRIM [Internet]. 2019 Sep. 27 [cited 2026 Nov. 3];6(10). Available from: https://ejcrim.com/index.php/ejcrim/article/view/1236

Most read articles by the same author(s)